Leveraging Real-World Evidence to Drive Advances in Oncology Care in the Asia-Pacific Region: Recommendations From the Asia-Pacific Oncology Drug Development Consortium Working Group.

Herbert H Loong¹, Pankaj Kumar Panda², Ben Tran³, Toshio Shimizu⁴, Pei Jye Voon⁵, Frederic Ivan Leong Ting^6,7, Takafumi Koyama⁸, Daphne Day⁹, K Arnold Chan^10,11, Grace L Wong¹², Daniel S W Tan¹³

¹Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.

²Clinical Research Secretariat, Apollo Proton Cancer Centre, Chennai, India.

³Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

⁴Department of New Experimental Therapeutics, Early-Phase 1 Drug Development Service, Kansai Medical University Hospital, Osaka, Japan.

⁵Department of Radiotherapy and Oncology, Hospital Umum Sarawak, Sarawak, Malaysia.

⁶Department of Clinical Sciences, College of Medicine, University of St La Salle, Bacolod City, Philippines.

⁷Department of Medicine, Section of Oncology, Corazon Locsin Montelibano Memorial Regional Hospital, Bacolod, Philippines.

⁸Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.

⁹Department of Oncology, Monash Health and Monash University, Bentleigh, VIC, Australia.

¹⁰Health Data Research Center, National Taiwan University, Taipei, Taiwan.

¹¹TriNetX, LLC, Cambridge, MA.

¹²Department of Medicine & Therapeutics, Medical Data Analytics Centre (MDAC), The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.

¹³Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.

PubMed DOI

Abstract

In an era of rapid technological advancements, the Asia-Pacific (APAC) region stands at the forefront of health care innovation, leveraging real-world evidence (RWE) to drive transformative changes. RWE, derived from real-world data such as electronic health records and patient registries, provides actionable insights that supplement clinical trial data, thus enhancing clinical decision making and…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.